Diana Cepeda

Diana Cepeda is currently the Vice President of Research & Development at SparingVision, where they continue to advance innovations in gene therapy and translational biology. They previously served as R&D Consultant at the same company and held various senior scientific positions including Executive Director of Novel Vector Technology at Adverum Biotechnologies, Inc. Diana completed a PhD in Medical Science with a focus on experimental oncology at Karolinska Institutet, and holds multiple degrees in molecular biology and cell biology from Uppsala University and The University of British Columbia. Their extensive research experience encompasses collaborations and innovations in gene editing and therapeutic methods across various institutions.